Hand-out
Press Releases
etherna Announces Strategic Multi-Target Collaboration with Dropshot Therapeutics
NIEL, Belgium and BOSTON, Jan. 9, 2025 /PRNewswire/ -- etherna immunotherapies NV ("etherna"), a technology platform leader pioneering mRNA and lipid-based nanoparticle (LNP) technologies, announces a strategic collaboration with Dropshot
